FDA Updates Policy for AI-Enabled Health Technologies
The FDA has updated its policies to ease approval paths for AI-enabled clinical decision support software and consumer wearables, expanding enforcement discretion for specific functions. This shift promotes innovation in digital health while ensuring oversight in critical care.